Open AccessCOVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
Author(s) -
Swathi Beladakere Ramaswamy,
Raghav Govindarajan
Publication year - 2020
Publication title -
journal of neuromuscular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.366
H-Index - 23
eISSN - 2214-3602
pISSN - 2214-3599
DOI - 10.3233/jnd-200520
Subject(s) - myasthenia gravis , refractory (planetary science) , medicine , covid-19 , pandemic , pediatrics , virology , disease , outbreak , physics , astrobiology , infectious disease (medical specialty)
This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.